Quality-Adjusted Life Expectancy Norms Based on the EQ-5D-5L and SF-6Dv2 for China

Overview

Journal Appl Health Econ Health Policy

Specialty Public Health

Date 2024 Dec 13

PMID 39672996

Authors

Shitong Xie

Xiaoning He

Weihua Guo

Jing Wu

Affiliations

Soon will be listed here.

Abstract

Objectives: Quality-adjusted life expectancy (QALE) norms reflect the normative profiles or reference data of QALE of the general population and provide a meaningful anchor for comparison to inform healthcare decision-making. This study aimed to develop the QALE norms for the Chinese population by using a representative dataset of health utility values collected using the EQ-5D-5L and short-form 6-dimension version 2 (SF-6Dv2) instruments.

Methods: Age-specific population norms of health utility values calculated using the EQ-5D-5L and SF-6Dv2 were used. Both utility norms were combined with the latest version of the National Life Tables of China published in 2021 to calculate QALE estimates on the basis of age, sex, and urban/rural residence area. QALE estimates were further discounted using 1.5%, 3.5%, 5.0%, and 8.0% discount rates.

Results: When using the health utility values evaluated by the SF-6Dv2, the QALE at age 0 years was 66.34 years at the discount rate of 0% and 16.65 years at the discount rate of 5%. For the EQ-5D-5L, the QALE at age 0 years was 76.50 years at the discount rate of 0% and 19.45 years at the discount rate of 5%. At birth, females exhibited a higher QALE, while the difference between females and males initially increased before subsequently declining overtime, ultimately resulting in females having a lower QALE. Rural population had a monotonically lower QALE than urban population.

Conclusion: This study constructed age-stratified QALE norms for the Chinese population categorized by sex and residence area using mortality data alongside corresponding health utility values derived from the EQ-5D-5L and SF-6Dv2.

References

Murray C, Salomon J, Mathers C . A critical examination of summary measures of population health. Bull World Health Organ. 2000; 78(8):981-94. PMC: 2560826. View

Love-Koh J, Schneider P, McNamara S, Doran T, Gutacker N . Decomposition of Quality-Adjusted Life Expectancy Inequalities by Mortality and Health-Related Quality of Life Dimensions. Pharmacoeconomics. 2023; 41(7):831-841. PMC: 10232554. DOI: 10.1007/s40273-023-01264-9. View

Gutacker N, Kinge J, Olsen J . Inequality in quality-adjusted life expectancy by educational attainment in Norway: an observational study. BMC Public Health. 2023; 23(1):805. PMC: 10155341. DOI: 10.1186/s12889-023-15663-2. View

Jo M, Seo W, Lim S, Ock M . The Trends in Health Life Expectancy in Korea according to Age, Gender, Education Level, and Subregion: Using Quality-Adjusted Life Expectancy Method. J Korean Med Sci. 2019; 34(Suppl 1):e88. PMC: 6434147. DOI: 10.3346/jkms.2019.34.e88. View

Mathers C, Murray C, Salomon J, Sadana R, Tandon A, Lopez A . Healthy life expectancy: comparison of OECD countries in 2001. Aust N Z J Public Health. 2004; 27(1):5-11. DOI: 10.1111/j.1467-842x.2003.tb00372.x. View

Robine J, Ritchie K . Healthy life expectancy: evaluation of global indicator of change in population health. BMJ. 1991; 302(6774):457-60. PMC: 1669345. DOI: 10.1136/bmj.302.6774.457. View

Murray C . Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994; 72(3):429-45. PMC: 2486718. View

Bryan S, Longworth L . Measuring health-related utility: why the disparity between EQ-5D and SF-6D?. Eur J Health Econ. 2005; 6(3):253-60. DOI: 10.1007/s10198-005-0299-9. View

Badia X, Roset M, Herdman M, Kind P . A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001; 21(1):7-16. DOI: 10.1177/0272989X0102100102. View

10.

Kind P, Dolan P, Gudex C, Williams A . Variations in population health status: results from a United Kingdom national questionnaire survey. BMJ. 1998; 316(7133):736-41. PMC: 28477. DOI: 10.1136/bmj.316.7133.736. View

11.

Brazier J, Roberts J, Deverill M . The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002; 21(2):271-92. DOI: 10.1016/s0167-6296(01)00130-8. View

12.

Brazier J, Usherwood T, Harper R, Thomas K . Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998; 51(11):1115-28. DOI: 10.1016/s0895-4356(98)00103-6. View

13.

McNamara S, Schneider P, Love-Koh J, Doran T, Gutacker N . Quality-Adjusted Life Expectancy Norms for the English Population. Value Health. 2022; 26(2):163-169. DOI: 10.1016/j.jval.2022.07.005. View

14.

Ghetti G, Povero M . Quality-Adjusted Life Expectancy Norms for Italy. Value Health. 2023; 26(7):1133-1134. DOI: 10.1016/j.jval.2023.03.012. View

15.

Gheorghe M, Wubulihasimu P, Peters F, Nusselder W, van Baal P . Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level. Eur J Public Health. 2016; 26(5):794-799. DOI: 10.1093/eurpub/ckw043. View

16.

Matsuyama Y, Tsakos G, Listl S, Aida J, Watt R . Impact of Dental Diseases on Quality-Adjusted Life Expectancy in US Adults. J Dent Res. 2019; 98(5):510-516. DOI: 10.1177/0022034519833353. View

17.

Scohy A, Charafeddine R, Van Wilder L, Van Oyen H, De Smedt D, Devleesschauwer B . Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018. Arch Public Health. 2022; 80(1):254. PMC: 9758921. DOI: 10.1186/s13690-022-01011-0. View

18.

Liu G, Wu J, He X, Jiang Y . Policy Updates on Access to and Affordability of Innovative Medicines in China. Value Health Reg Issues. 2022; 30:59-66. DOI: 10.1016/j.vhri.2021.12.003. View

19.

Norman R, Cronin P, Viney R, King M, Street D, Ratcliffe J . International comparisons in valuing EQ-5D health states: a review and analysis. Value Health. 2009; 12(8):1194-200. DOI: 10.1111/j.1524-4733.2009.00581.x. View

20.

Xie F, Gaebel K, Perampaladas K, Doble B, Pullenayegum E . Comparing EQ-5D valuation studies: a systematic review and methodological reporting checklist. Med Decis Making. 2013; 34(1):8-20. DOI: 10.1177/0272989X13480852. View